20 June 2013
Keywords: gw, relenza, slated, october, launch, glaxo, wellcome
Article | 26 August 1999
Glaxo Wellcome's influenza drug Relenza (zanamivir) is scheduled to belaunched in Europe in October. Although exact pricing will not be ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.